La Spada Emanuele, La Spada Monica, Brusca Tiziana, Campagna M Elisa, Di Gesaro Valeria, Terranova Angela, Sandonato Luigi, Soresi Maurizio
Cattedra di Medicina Interna e d'Urgenza, Università, Palermo.
Recenti Prog Med. 2007 Apr;98(4):232-5.
Transarterial chemoembolization (TACE) is included among the wide therapeutic tools for the treatment of hepatocellular carcinoma (HCC), tumour with high frequency and malignancy. The approach is invasive and, beyond the discomfort for the patient, it is charged by a number of side effects and complications. In this study we report the case of renal acute failure of hypovolemic origin, as a consequence of a TACE in a patient suffering from HCC, occurred after one week of intervention. The different possible mechanisms involved in the pathogenesis of this complication are discussed.
经动脉化疗栓塞术（TACE）是治疗肝细胞癌（HCC）的众多治疗手段之一，肝细胞癌是一种高发性和高恶性肿瘤。这种方法具有侵入性，除了给患者带来不适外，还伴随着许多副作用和并发症。在本研究中，我们报告了1例肝细胞癌患者在接受TACE治疗1周后发生低血容量性肾急性衰竭的病例。文中讨论了该并发症发病机制中涉及的不同可能机制。
